FDA Inspection 1229390 — BOLIVE INC
The FDA completed an inspection of BOLIVE INC on March 14, 2024 in Los Angeles, CA. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Food/Cosmetics.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- March 14, 2024
- Fiscal Year
- 2024
- Product Type
- Food/Cosmetics
- Project Area
- Foodborne Biological Hazards
- Location
- Los Angeles, CA (United States)
Additional Details
FSVP